Hangzhou AGS MedTech Co. Ltd. A (688581) — Cash Flow Reinvestment Rate
Hangzhou AGS MedTech Co. Ltd. A (688581) has a Cash Flow Reinvestment Rate of 0.42x as of December 2025, reinvesting CN¥63.47 Million (capex CN¥63.47 Million ) from operating cash flow of CN¥151.20 Million. Check Hangzhou AGS MedTech Co. Ltd. A earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hangzhou AGS MedTech Co. Ltd. A Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Hangzhou AGS MedTech Co. Ltd. A across 5 annual periods. Explore debt repayment capacity of Hangzhou AGS MedTech Co. Ltd. A to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Hangzhou AGS MedTech Co. Ltd. A (2021–2025)
Year-by-year capital reinvestment analysis for Hangzhou AGS MedTech Co. Ltd. A. For live market cap and broader valuation context, see 688581 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CN¥63.47 Million | CN¥151.20 Million | CN¥63.47 Million | ▲ +167.2% |
| 2024 | 0.16x | CN¥49.60 Million | CN¥315.80 Million | CN¥49.60 Million | ▼ -32.6% |
| 2023 | 0.23x | CN¥51.57 Million | CN¥221.45 Million | CN¥51.57 Million | ▼ -39.4% |
| 2022 | 0.38x | CN¥60.12 Million | CN¥156.38 Million | CN¥60.12 Million | ▲ +179.0% |
| 2021 | 0.14x | CN¥16.29 Million | CN¥118.25 Million | CN¥15.66 Million | — |